Human hepatitis B immunoglobulin (Hualan Biological Engineering)
乙型肝炎人免疫球蛋白 （华兰生物工程股份有限公司）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameHuman hepatitis B immunoglobulin (Hualan Biological Engineering)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2002/01/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHualan Ankang Biotechnology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesHualan Ankang Biotechnology Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A